MarketsStocksAAREYDRUGS
AA

Aarey Drugs & Pharmaceuticals Limited

NSE: AAREYDRUGSBSE: 524412Healthcare
Download Research Report7-page PDF
79.80
+2.94%
NSE · auto-updates while market open
Prev Close
₹55.19
Day High
₹80.00
Day Low
₹74.81
Mkt Cap
₹224 Cr
P / E
49.6
P / B
1.5
ROE
3.1%
52W High
₹100.00
52W Low
₹47.76
Key Metrics
Market Cap
₹224 Cr
P / E
49.57
P / B
1.48
EV / EBITDA
37.91
ROCE
5.6%
ROE
3.1%
Debt / Equity
0.33
Book Value
₹52.86
EPS
₹1.39
Div Yield
0.0%
Face Value
-
Promoter Holding
37.7%
Revenue · ₹ Cr
493
FY22
62
FY23
396
FY24
474
FY25
472
FY26
Net Profit · ₹ Cr
8
FY22
0
FY23
5
FY24
4
FY25
4
FY26
EPS · ₹ per share
₹2.7
FY22
₹0.2
FY23
₹1.8
FY24
₹1.4
FY25
₹1.4
FY26
P / E Ratio · price ÷ TTM EPS
0128256384310-0Mar 22Aug 23Jan 25Jun 26
P/E 41.0×Median 32.4×TTM EPS
Q1 2026 snapshot
Sales
₹189 Cr
Operating profit
-
OPM
-
Net profit
₹2 Cr
EPS
₹0.55
Scorecard · 7 axes
Quality
Weak
37/100
Valuation
Weak
49.6×
Growth
Bad
-7.9%
Profitability
Bad
4.3%
Performance
Good
+47.2%
Entry Point
Good
80%
Red Flags
Strong
0 flags
Shareholding Pattern
37.7%Promoter
Promoter37.7%
FII4.2%
DII1.6%
Public56.5%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue134.47115.64103.7684.95100.61189.04
Net Profit0.7180.471.3721.0240.571.557
NPM %0.5%0.4%1.3%1.2%0.6%0.8%
AlertPre-trade